AMEX · TRX
TRX Gold Corporation
$1.02-$0.03 (-2.39%)
TRX Gold Corporation’s quoted price sits in the lower half of its reported 52-week range, 63.57% below the high.
Loading market information…
NASDAQ · BHST · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BioHarvest Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
BioHarvest Sciences Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow BioHarvest Sciences Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 15, 2025 | -$0.13+13.33% vs estimate | $7.84M-8.17% vs estimate |
|---|
| Q4 2024 | Mar 31, 2025 | -$0.17-41.67% vs estimate | $7.28M+0.55% vs estimate |
|---|
| Q3 2024 | Nov 25, 2024 | -$0.16-220.0% vs estimate | $6.54M-9.66% vs estimate |
|---|
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $5.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.02-$0.03 (-2.39%)
TRX Gold Corporation’s quoted price sits in the lower half of its reported 52-week range, 63.57% below the high.
$43.17+$0.35 (+0.82%)
Friedman Industries, Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.48% below the high.
$5.69-$0.11 (-1.9%)
FutureFuel Corp.’s quoted price sits in the upper half of its reported 52-week range, 18.6% below the high.
$22.52+$0.33 (+1.49%)
Core Molding Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 21.51% below the high.
$13.80+$0.19 (+1.4%)
Ascent Industries Co.’s quoted price sits in the lower half of its reported 52-week range, 22.99% below the high.
$5.60+$0.20 (+3.61%)
U.S. GoldMining Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.88% below the high.
$1.10-$0.04 (-3.51%)
American Vanguard Corporation’s quoted price sits in the lower half of its reported 52-week range, 80.18% below the high.
$0.23-$0.02 (-7.76%)
Bioceres Crop Solutions Corp.’s quoted price sits in the lower half of its reported 52-week range, 89.07% below the high.
